{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:01:32Z","timestamp":1783728092217,"version":"3.55.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biocel.2022.106273","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T21:21:21Z","timestamp":1659388881000},"page":"106273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Mechanisms of NLRP3 activation and pathology during neurodegeneration"],"prefix":"10.1016","volume":"151","author":[{"given":"Sara","family":"Jose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrein E.","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","volume":"18","author":"2022 Alzheimer\u2019s disease facts and figures","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/jcbfm.2013.236","article-title":"Pyroptotic neuronal cell death mediated by the AIM2 inflammasome","volume":"34","author":"Adamczak","year":"2014","journal-title":"J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.biocel.2022.106273_bib3","first-page":"41","article-title":"Inflammasomes in CNS diseases","volume":"108","author":"Albornoz","year":"2018","journal-title":"Exp. Suppl. (2012)"},{"issue":"8","key":"10.1016\/j.biocel.2022.106273_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biocel.2022.106273_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.intimp.2017.10.024","article-title":"TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer\u2019s disease","volume":"54","author":"Aminzadeh","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib6","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biocel.2022.106273_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701282","article-title":"Activation of NLRP3 inflammasome and onset of Alzheimer\u2019s disease","volume":"12","author":"Bai","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2022.106273_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701282","article-title":"Activation of NLRP3 inflammasome and onset of Alzheimer\u2019s disease [review]","volume":"12","author":"Bai","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biocel.2022.106273_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jnr.20266","article-title":"Interleukin-1: a master regulator of neuroinflammation [https:\/\/doi.org\/10.1002\/jnr.20266]","volume":"78","author":"Basu","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib11","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases (review)","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.biocel.2022.106273_bib12","doi-asserted-by":"crossref","first-page":"15620","DOI":"10.18632\/aging.203125","article-title":"Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer's disease cell and mouse models for neuroprotection and cognitive improvement","volume":"13","author":"Chiu","year":"2021","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055375","article-title":"Triggering of inflammasome by aggregated \u03b1-synuclein, an inflammatory response in synucleinopathies","volume":"8","author":"Codolo","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biocel.2022.106273_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biocel.2022.106273_bib15","doi-asserted-by":"crossref","first-page":"12504","DOI":"10.1038\/ncomms12504","article-title":"Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models","volume":"7","author":"Daniels","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bpa.12467","article-title":"Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice","volume":"28","author":"Debye","year":"2018","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.biocel.2022.106273_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.23728","article-title":"The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins","volume":"68","author":"Deora","year":"2020","journal-title":"Glia"},{"issue":"S1","key":"10.1016\/j.biocel.2022.106273_bib18","first-page":"S3","article-title":"The emerging evidence of the parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biocel.2022.106273_bib19","article-title":"Roles of pro- and anti-inflammatory cytokines in traumatic brain injury and acute ischemic","author":"Dugue","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.biocel.2022.106273_bib20","series-title":"Economic Analysis of Motor Neurone Disease in Australia","author":"Economics","year":"2015"},{"key":"10.1016\/j.biocel.2022.106273_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0350-4","article-title":"Humoral factors in ALS patients during disease progression","volume":"12","author":"Ehrhart","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biocel.2022.106273_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci."},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12974-017-1036-x","article-title":"Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia","volume":"14","author":"Fan","year":"2017","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","article-title":"Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease","volume":"17","author":"Fan","year":"2020","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.biocel.2022.106273_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biocel.2022.106273_bib26","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2147\/JIR.S304461","article-title":"MicroRNA-138-5p regulates hippocampal neuroinflammation and cognitive impairment by NLRP3\/caspase-1 signaling pathway in rats","volume":"14","author":"Feng","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.biocel.2022.106273_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.746631","article-title":"Sirtuins as potential therapeutic targets for mitigating neuroinflammation associated with Alzheimer\u2019s disease [review]","volume":"15","author":"Fernando","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib28","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1038\/s41467-018-06449-x","article-title":"Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer\u2019s disease mouse model","volume":"9","author":"Flores","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biocel.2022.106273_bib29","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.celrep.2020.02.025","article-title":"\u03b2-amyloid clustering around ASC fibrils boosts its toxicity in microglia","volume":"30","author":"Friker","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.biocel.2022.106273_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in Parkinson\u2019s disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"5493","key":"10.1016\/j.biocel.2022.106273_bib31","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biocel.2022.106273_bib32","first-page":"175","article-title":"Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis","volume":"21","author":"Gon\u00e7alves","year":"2014","journal-title":"Amyloid: Int. J. Exp. Clin. Investig.: Off. J. Int. Soc. Amyloidosis"},{"issue":"465","key":"10.1016\/j.biocel.2022.106273_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biocel.2022.106273_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mcn.2018.11.002","article-title":"Cyclo(His-Pro) inhibits NLRP3 inflammasome cascade in ALS microglial cells","volume":"94","author":"Grottelli","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"issue":"37","key":"10.1016\/j.biocel.2022.106273_bib35","article-title":"Key mechanisms and potential targets of the NLRP3 inflammasome in neurodegenerative diseases [review]","volume":"14","author":"Guan","year":"2020","journal-title":"Front. Integr. Neurosci."},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10753-017-0667-5","article-title":"NLRP3 inflammasome activation in a transgenic amyotrophic lateral sclerosis model","volume":"41","author":"Gugliandolo","year":"2018","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.biocel.2022.106273_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20150617","article-title":"Amyloid fibrils are the molecular trigger of inflammation in Parkinson\u2019s disease","volume":"471","author":"Gustot","year":"2015","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.biocel.2022.106273_bib38","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.biocel.2022.106273_bib39","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","article-title":"Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease","volume":"15","author":"Han","year":"2019","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.biocel.2022.106273_bib40","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.4049\/jimmunol.1200312","article-title":"Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1\u03b2 production","volume":"189","author":"Haneklaus","year":"2012","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.biocel.2022.106273_bib41","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.biocel.2022.106273_bib42","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/acschemneuro.1c00831","article-title":"Novel small-molecule inhibitor of NLRP3 inflammasome reverses cognitive impairment in an Alzheimer\u2019s disease model","volume":"13","author":"Haseeb","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib43","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biocel.2022.106273_bib44","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ni.2257","article-title":"Inflammasomes: far beyond inflammation","volume":"13","author":"Henao-Mejia","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biocel.2022.106273_bib46","first-page":"73","article-title":"Chapter three \u2013 the intestinal microbiota in chronic liver disease","volume":"117","author":"Henao-Mejia","year":"2013"},{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.biocel.2022.106273_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"7434","key":"10.1016\/j.biocel.2022.106273_bib49","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib50","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"issue":"7784","key":"10.1016\/j.biocel.2022.106273_bib51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biocel.2022.106273_bib52","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/glia.22891","article-title":"NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients","volume":"63","author":"Johann","year":"2015","journal-title":"Glia"},{"issue":"7371","key":"10.1016\/j.biocel.2022.106273_bib53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"issue":"42","key":"10.1016\/j.biocel.2022.106273_bib54","doi-asserted-by":"crossref","first-page":"44161","DOI":"10.18632\/oncotarget.6592","article-title":"Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib55","first-page":"537","volume":"77","author":"Komine","year":"2015","journal-title":"Nagoya J. Med. Sci."},{"issue":"8","key":"10.1016\/j.biocel.2022.106273_bib56","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jnr.24004","article-title":"The function of NOD-like receptors in central nervous system diseases","volume":"95","author":"Kong","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060921","article-title":"Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology","volume":"8","author":"Krabbe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2022.106273_bib58","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3233\/JAD-210400","article-title":"A novel inhibitor targeting NLRP3 inflammasome reduces neuropathology and improves cognitive function in Alzheimer\u2019s disease transgenic mice","volume":"82","author":"Kuwar","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.biocel.2022.106273_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2013.00016","article-title":"The role of sirtuins in Alzheimer\u2019s disease","volume":"5","author":"Lalla","year":"2013","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.biocel.2022.106273_bib60","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11064-014-1304-4","article-title":"Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer\u2019s disease","volume":"39","author":"Liang","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biocel.2022.106273_bib61","article-title":"The role of NLRP3 inflammasome in Alzheimer\u2019s disease and potential therapeutic targets [review]","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biocel.2022.106273_bib62","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biocel.2022.106273_bib63","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1474-4422(18)30404-6","article-title":"Global, regional, and national burden of motor neuron diseases 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Logroscino","year":"2018","journal-title":"Lancet Neurol."},{"issue":"50","key":"10.1016\/j.biocel.2022.106273_bib64","doi-asserted-by":"crossref","first-page":"32145","DOI":"10.1073\/pnas.2009680117","article-title":"The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"117","author":"Lonnemann","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biocel.2022.106273_bib65","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"issue":"315","key":"10.1016\/j.biocel.2022.106273_bib66","article-title":"IL-1 family cytokines trigger sterile inflammatory disease [review]","volume":"3","author":"Lukens","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2022.106273_bib67","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-020-09993-z","article-title":"The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis","author":"Lunetta","year":"2020","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.biocel.2022.106273_bib68","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.biocel.2022.106273_bib69","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrd.2018.149","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biocel.2022.106273_bib70","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s11064-017-2185-0","article-title":"The NLRP3 inflammasome is involved in the pathogenesis of Parkinson\u2019s disease in rats","volume":"42","author":"Mao","year":"2017","journal-title":"Neurochem. Res."},{"issue":"7","key":"10.1016\/j.biocel.2022.106273_bib71","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biocel.2022.106273_bib72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biocel.2022.106273_bib73","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","article-title":"The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer\u2019s disease","volume":"68","author":"Milner","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biocel.2022.106273_bib74","series-title":"Chronic Inflammation Mechanisms and Regulation","author":"Miyasaka","year":"2016"},{"issue":"5","key":"10.1016\/j.biocel.2022.106273_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052523","article-title":"Inflammasome in ALS skeletal muscle: NLRP3 as a potential biomarker","volume":"22","author":"Moreno-Garc\u00eda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biocel.2022.106273_bib76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-10-4","article-title":"A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion","volume":"10","author":"Morrison","year":"2013","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.biocel.2022.106273_bib77","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Mu\u00f1oz-Planillo","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12974-020-01778-5","article-title":"The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target","volume":"17","author":"O\u2019Brien","year":"2020","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib79","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41232-020-00137-4","article-title":"Cerebral sterile inflammation in neurodegenerative diseases","volume":"40","author":"Otani","year":"2020","journal-title":"Inflamm. Regen."},{"issue":"6","key":"10.1016\/j.biocel.2022.106273_bib80","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1084\/jem.20182191","article-title":"Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biocel.2022.106273_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00036","article-title":"Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation","volume":"8","author":"Pellegrini","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biocel.2022.106273_bib82","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biocel.2022.106273_bib83","article-title":"Update on the management of Parkinson\u2019s disease for general neurologists","volume":"2020","author":"Pirto\u0161ek","year":"2020","journal-title":"Park.\u2019s Dis."},{"issue":"7685","key":"10.1016\/j.biocel.2022.106273_bib84","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/d41586-017-08668-6","article-title":"Specks of insight into Alzheimer's disease","volume":"552","author":"Ransohoff","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biocel.2022.106273_bib85","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2174\/138955709789055199","article-title":"Peripheral chemo-cytokine profiles in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"9","author":"Reale","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.biocel.2022.106273_bib86","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023572","article-title":"The three-dimensional structures of amyloids","volume":"9","author":"Riek","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biocel.2022.106273_bib87","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainresbull.2019.10.010","article-title":"Involvement of NLRC4 inflammasome through caspase-1 and IL-1\u03b2 augments neuroinflammation and contributes to memory impairment in an experimental model of Alzheimer\u2019s like disease","volume":"154","author":"Saadi","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biocel.2022.106273_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00394","article-title":"Biological and clinical implications of comorbidities in Parkinson\u2019s disease","volume":"9","author":"Santiago","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biocel.2022.106273_bib89","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","article-title":"The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease","volume":"11","author":"Saresella","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.biocel.2022.106273_bib90","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2022.106273_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00320","article-title":"Targeting NLRP3 inflammasome in the treatment of CNS diseases","volume":"11","author":"Shao","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"262","key":"10.1016\/j.biocel.2022.106273_bib92","article-title":"NLRP3 inflammasome and its inhibitors: a review [review]","volume":"6","author":"Shao","year":"2015","journal-title":"Front. Pharm."},{"issue":"5","key":"10.1016\/j.biocel.2022.106273_bib93","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s12026-016-8873-z","article-title":"Inflammasomes and its importance in viral infections","volume":"64","author":"Shrivastava","year":"2016","journal-title":"Immunol. Res."},{"issue":"7","key":"10.1016\/j.biocel.2022.106273_bib94","first-page":"243","article-title":"Neurotoxicity by microglia: the mechanisms and potential therapeutic strategy","volume":"100","author":"Suzumura","year":"2009","journal-title":"Fukuoka Igaku Zasshi"},{"issue":"923","key":"10.1016\/j.biocel.2022.106273_bib95","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/pmj.78.923.513","article-title":"Motor neurone disease","volume":"78","author":"Talbot","year":"2002","journal-title":"Postgrad. Med. J."},{"issue":"8","key":"10.1016\/j.biocel.2022.106273_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.348","article-title":"Amyloid-\u03b2 induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer\u2019s disease","volume":"5","author":"Tan","year":"2014","journal-title":"Cell Death Dis."},{"issue":"1\u20132","key":"10.1016\/j.biocel.2022.106273_bib97","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2013.10.002","article-title":"NLRP3 polymorphisms are associated with late-onset Alzheimer\u2019s disease in Han Chinese","volume":"265","author":"Tan","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"7685","key":"10.1016\/j.biocel.2022.106273_bib98","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer's disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2022.106273_bib99","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810248","article-title":"Inflammasomes in neuroinflammatory and neurodegenerative diseases","volume":"11","author":"Voet","year":"2019","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.biocel.2022.106273_bib100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrn3638","article-title":"Inflammasomes in the CNS","volume":"15","author":"Walsh","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.biocel.2022.106273_bib101","article-title":"Oridonin attenuates synaptic loss and cognitive deficits in an A\u03b21-42-induced mouse model of Alzheimer\u2019s disease","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"34","key":"10.1016\/j.biocel.2022.106273_bib102","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson\u2019s disease-associated protein \u03b1-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biocel.2022.106273_bib103","unstructured":"WHO, 2021. Dementia. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia\u3009."},{"issue":"7","key":"10.1016\/j.biocel.2022.106273_bib104","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD)","volume":"31","author":"Williams-Gray","year":"2016","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.biocel.2022.106273_bib105","first-page":"406","article-title":"Parkinson disease in the elderly adult","volume":"110","author":"Willis","year":"2013","journal-title":"Mo. Med."},{"issue":"7628","key":"10.1016\/j.biocel.2022.106273_bib106","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib107","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1038\/s41467-018-06522-5","article-title":"Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biocel.2022.106273_bib108","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1007\/s12035-019-1638-7","article-title":"The role of neuronal NLRP1 inflammasome in Alzheimer\u2019s disease: bringing neurons into the neuroinflammation game","volume":"56","author":"Yap","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib109","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1471-4159.2003.01652.x","article-title":"Interaction between flavonoids and the blood\u2013brain barrier: in vitro studies","volume":"85","author":"Youdim","year":"2003","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.biocel.2022.106273_bib110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biocel.2022.106273_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.512097","article-title":"Gender differences of NLRP1 inflammasome in mouse model of Alzheimer\u2019s disease","volume":"12","author":"Zhang","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biocel.2022.106273_bib112","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/NDT.S279304","article-title":"Bushen huoxue acupuncture inhibits NLRP1 inflammasome-mediated neuronal pyroptosis in SAMP8 mouse model of Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.biocel.2022.106273_bib113","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"Faseb J."},{"key":"10.1016\/j.biocel.2022.106273_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111822","article-title":"Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases","volume":"185","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biocel.2022.106273_bib115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","article-title":"TDP-43 activates microglia through NF-\u03baB and NLRP3 inflammasome","volume":"273","author":"Zhao","year":"2015","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.biocel.2022.106273_bib116","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272522001182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272522001182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:23:50Z","timestamp":1761204230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272522001182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":116,"alternative-id":["S1357272522001182"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2022.106273","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of NLRP3 activation and pathology during neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2022.106273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106273"}}